NASDAQ

AMRX

Amneal Pharmaceuticals, Inc. Class A

−0.57 (−2.83%) TodayNov 4, 11:44 AM ET

Mkt Cap
$6.8B
Volume
1.3M
52W High
$21.68
52W Low
$10.68
PE Ratio
43.5
Avg Vol
3.8M
As of 11/2/26
Div Yield
—
Beta
0.65
As of 11/2/26

Company

Employees
8,500 (2026)
Listed
May 7, 2018
Exchange
Nasdaq
Website
amneal.com
SEC industry
Pharmaceutical Preparations

Pharmaceuticals

  • Market cap #40 of 430
  • P/B #3 of 396

Ranked highest first among stocks Cylvex covers.

  1. LLYEli Lilly and Company$1.28T+1.60%
  2. JNJJohnson & Johnson$655.1B+2.23%
  3. ABBVAbbVie Inc$511.0B+1.12%
  4. MRKMerck & Co Inc$365.6B+2.44%
  5. NVSNovartis AG$310.9B+3.38%
All Pharmaceuticals ›

Financial summary

Related companies

About

Amneal Pharmaceuticals Inc is a pharmaceutical company operating in the U.S., India, and Ireland. With three reportable segments; Affordable Medicines, Specialty, and AvKARE. It develops, manufactures, and distributes a diverse portfolio of essential medicines. The Affordable Medicines segment, which derives maximum revenue, focuses on a wide range of dosage forms and delivery systems, contributing significantly to revenues. The Specialty segment promotes proprietary branded pharmaceuticals, particularly targeting the central nervous system and endocrine disorders. The AvKARE segment provides pharmaceuticals and medical products to governmental agencies, specializing in re-packaging and wholesale distribution, with a focus on offering consistent care and pricing to qualified entities.

From company filings and market data · Not investment advice

Price data

Day Low $15.54Day High $20.71
52W Low $10.6852W High $21.68
Open
$20.55
Prev Close
$20.21
Volume
1.3M
Avg Vol (30D)
3.9M

From daily bars

Financials

Consensus estimates

The information provided is for educational purposes only and does not constitute investment advice. Past performance does not guarantee future results.